Stevanato Group (NYSE:STVN - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.530-0.570 for the period, compared to the consensus earnings per share estimate of 0.580. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on the stock. Stephens raised shares of Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. UBS Group cut their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a report on Friday, March 7th. Finally, William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Stevanato Group presently has an average rating of "Moderate Buy" and a consensus price target of €25.70 ($28.56).
Check Out Our Latest Analysis on STVN
Stevanato Group Trading Up 3.0%
Shares of STVN stock traded up €0.70 ($0.78) during trading hours on Tuesday, reaching €24.36 ($27.07). 178,625 shares of the stock were exchanged, compared to its average volume of 348,544. The firm has a market capitalization of $7.38 billion, a price-to-earnings ratio of 51.83, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 12-month low of €16.56 ($18.40) and a 12-month high of €24.90 ($27.67). The company's 50-day moving average price is €21.22 and its 200-day moving average price is €21.04.
Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, meeting analysts' consensus estimates of €0.20 ($0.22). The company had revenue of €352.68 million during the quarter, compared to analysts' expectations of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, equities analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current year.
Stevanato Group Increases Dividend
The company also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be issued a $0.0613 dividend. This is a boost from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date is Thursday, June 5th. This represents a yield of 0.3%. Stevanato Group's payout ratio is presently 11.76%.
About Stevanato Group
(
Get Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Further Reading
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
